HP
CRBP icon

HealthInvest Partners’s Corbus Pharmaceuticals CRBP Stock Holding History

HealthInvest Partners’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-107,255
Closed -$873K – 42
2025
Q4 		$873K Sell
107,255
-68,327
-39% -$843K 0.28% 38
2025
Q3 		$2.22M Hold
175,582
– – 0.87% 32
2025
Q2 		$1.21M Buy
175,582
+77,278
+79% +$561K 0.52% 36
2025
Q1 		$522K Hold
98,304
– – 0.23% 36
2024
Q4 		$1.19M Buy
98,304
+28,731
+41% +$482K 0.56% 31
2024
Q3 		$1.44M Buy
69,573
+30,473
+78% +$1.56M 0.67% 30
2024
Q2 		$1.77M Buy
39,100
+1,100
+3% +$46.3K 1.08% 23
2024
Q1 		$1.49M Buy
+38,000
New +$937K 0.91% 29

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HealthInvest Partners's CRBP Position: Q1 2026 in Review

HealthInvest Partners sold out of Corbus Pharmaceuticals (CRBP) in Q1 2026, closing a stake of 107,255 shares — an estimated $873K sold.

HealthInvest Partners first reported a position in CRBP in Q1 2024 and held it in 8 quarters. The position peaked at $2.22M in Q3 2025. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • HealthInvest Partners reported no remaining Corbus Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • HealthInvest Partners sold 107,255 Corbus Pharmaceuticals shares in Q1 2026, an estimated $873K.
  • HealthInvest Partners first reported a position in Corbus Pharmaceuticals in Q1 2024 and held it in 8 quarters.
  • HealthInvest Partners's Corbus Pharmaceuticals position peaked at $2.22M in Q3 2025.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on HealthInvest Partners's 13F filing for Q1 2026, filed 11 May 2026.